EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent Advances in Mitochondria‐Localized Luminescent Ruthenium(II) Metallodrugs as Anticancer Agents

Sushree Aradhana Patra, Gurunath Sahu, Sanchita Das, Rupam Dinda iD

ChemMedChem · 16.11.2023 · 18 (22)

DOI: 10.1002/cmdc.202300397 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 30.10.2023. Verfasst von Sushree Aradhana Patra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India. Hauptthemen laut MEDLINE: Ruthenium, Coordination Complexes, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 152 Literaturangaben. Gefördert von: CSIR, Govt. of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Presently, the most effective way to transport drugs specifically to mitochondria inside the cells is of pharmacophoric interest, as mitochondria are recognized as one of the most important targets for new drug design in cancer diagnosis. To date, there are many reviews covering the photophysical, photochemical, and anticancer properties of ruthenium(II) based metallodrugs owing to their high interest in biological applications. There are, however, no reviews specifically covering the mitochondria‐localized luminescent Ru(II) complexes and their subsequent mitochondria‐mediated anticancer activities. Therefore, this review describes the physicochemical basis for the mitochondrial accumulation of ruthenium complexes, their synthetic strategies to localize and monitor the mitochondria in living cells, and their related underlying anticancer results. Finally, we review the related areas from previous works describing the mitochondria‐localized ruthenium complexes for the treatment of cancer‐related diseases. Along with this, we also deliberate the perspectives and future directions for emerging more bifunctional Ru(II) complexes that can target, image, and kill tumors more efficiently in comparison with the existing mitochondria‐targeted cancer therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RutheniumCoordination ComplexesAntineoplastic AgentsNeoplasmsHumansMitochondria

Stichwörter der Autor:innen

Anticancer activitiesLive cell imagingLuminescent Ru(II) complexesMitochondrial localization

Substanzen

RutheniumCoordination ComplexesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, National Institute of Technology, Rourkela, 769008, Odisha, India.

ORCID-Profile: Rupam Dinda

Förderung

  • CSIR, Govt. of India

Zitieren

APA

Patra, S. A., Sahu, G., Das, S., & Dinda, R. (2023). Recent Advances in Mitochondria‐Localized Luminescent Ruthenium(II) Metallodrugs as Anticancer Agents. ChemMedChem, 18(22). https://doi.org/10.1002/cmdc.202300397

Vancouver

Patra SA, Sahu G, Das S, Dinda R. Recent Advances in Mitochondria‐Localized Luminescent Ruthenium(II) Metallodrugs as Anticancer Agents. ChemMedChem. 2023;18(22). doi:10.1002/cmdc.202300397

BibTeX
@article{Patra2023,
  author = {Patra, Sushree Aradhana and Sahu, Gurunath and Das, Sanchita and Dinda, Rupam},
  title = {Recent Advances in Mitochondria‐Localized Luminescent Ruthenium(II) Metallodrugs as Anticancer Agents},
  journal = {ChemMedChem},
  year = {2023},
  volume = {18},
  number = {22},
  doi = {10.1002/cmdc.202300397}
}
Kostenlos starten →